Therapy-associated risk decision making in individuals with multiple system atrophy and Parkinson’s disease, THE YAMSA TRIAL
Objective: This study aimed to quantify the risk willingness of patients suffering from the α-synucleinopathies multiple system atrophy (MSA) and Parkinson's Disease (PD) and identify…Clinical-based diagnosis and self-reported Parkinson’s disease in a population-based sample in southern Brazil
Objective: To report the frequency of self-reported PD and the diagnostic evaluation performed by clinical neurologists in a population-based cohort from south Brazil. Background: It…Online education to promote compensation strategies for gait impairments in underserved Parkinson populations
Objective: Here, we explore the potential health benefits of using an online educational platform about compensation strategies for gait impairment in Parkinson’s disease (PD), in…Evoked resonant neural activity in Globus Pallidus vs. Subthalamic Nucleus of patients with Parkinson’s Disease, preliminary results
Objective: Compare the evoked resonant neural activity (ERNA) responses obtained from stimulation of Subthalamic Nucleus (STN) and Globus Pallidus Internus (GPi) in patients with Parkinson’s…How does a diagnosis of Dementia with Parkinson’s influence future care provision?
Objective: To describe the trajectory of Parkinson’s after the onset of dementia including setting of care, frailty levels and mortality rate. Background: Cardiff and Vale…Characterizing the neural response to electrical brain stimulation with spatiotemporal precision in mice.
Objective: An approach to characterize the neural response to electrical brain stimulation with spatiotemporal precision in mice. Background: Electrical brain stimulation is a clinically accessible…PFBC and dystonia: description of a cohort and peculiar cases
Objective: To describe dystonia in a PFBC cohort Background: Primary familial brain calcification (PFBC) is a rare neurodegenerative disorder characterized by calcium deposition in basal…Utility of quantitative EEG during sleep as a potential biomarker of Lewy body disease progression
Objective: Objective: To assess whether progression from isolated REM sleep behaviour disorder (iRBD), established Parkinson’s disease (PD) and Dementia with Lewy bodies (DLB) are accompanied…Incidence of childhood trauma in patients with functional movement disorder and its impact on motor symptoms severity
Objective: To assess the impact of self-reported childhood traumatic experience on motor symptoms severity in a group of patients with functional movement disorder (FMD). Background:…Does baseline expectation of benefit predict outcome in SURE-PD3, a Randomized, Double-Blind, Placebo-Controlled, Phase III trial of Inosine in Parkinson’s disease?
Objective: To evaluate the association of patient-reported baseline expectation with efficacy outcomes in a randomized placebo-controlled trial (RCT) in PD. Background: Expectation of benefit can…
- « Previous Page
- 1
- …
- 433
- 434
- 435
- 436
- 437
- …
- 1734
- Next Page »